INSTOR provides a breakdown of stroke sub-types by age, sex, and co-morbidities, with results further sub-divided by type of therapy, to include Intravenous tissue Plasminogen Activator (IV tPA) therapy, Endovascular Therapy (EVT) or none. Additionally, INSTOR is the only system that informs you on key aspects of your stroke patient population and their intrinsic risk factors (allowing for single or multifactorial risk-adjustment) through these numerous patient population statistics.
To get the full picture of your stroke population, INSTOR provides a full accounting of percentage of patients with various co-morbidities.
View a cross-section of your stroke population, and sub-group analysis, for those patients who are untreated, as well as those treated with IV tPA, IA therapy, or All. Results are compared with an anonymous national aggregate.